Trial Profile
An Investigative Study to characterize gene expression patterns in myeloid cells that are triggered during acute asthma exacerbations, and to identify associated genes/gene networks that are Omalizumab sensitive.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Sep 2020
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Pharmacodynamics; Pharmacogenomic
- 11 Sep 2020 Status changed from recruiting to completed.
- 30 Aug 2012 New trial record